The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Class of relevant security Purchase/sale Number of securities Price per unit 1p ordinary sale 332 830 140.58p no trades listed at this price.
When is it going to happen? Interested party declared in April.
no trades according to LSE
up 13% - nice one.
fantastic RNS
nice rns: "the financial performance of the Company for the first quarter of the year is significantly ahead of the Boards' expectations, comparative period performance and internal budgets."
Looking at this as the chart is looking good. Your posting intensity suggests you are familiar with the company. I have pasted an excerpt from the accounts posted on 1st April. Can you explain the following as i am having trouble understanding the complexity of their accounts: "The Group recorded a loss after taxation of £6,508,115 in the year ended 31 December 2015; however this included an exceptional non-cash finance charge of £8,066,000 based upon a revaluation of the embedded derivative associated with the Loan Notes issued by the Company in September 2013. The market value of the Company's Loan Notes is based upon the share price performance of the Company and only crystallises at the maturity date of 30 September 2018 or earlier on a change of control or scheme of arrangement." Thanks in advance
Go ne now..up we go.
that also !
very very good.
Up for takeover or jv. This could go nuts today ! All tiny snippets get reading folks.
GM..no payment required until 2018 and is totally dependant on share price 30 days prior to september 2018. although ultimately they dont think it will happen. (just bringing to shareholders attention)
final results..excellent.
3 rns's . A lot of reading to be done here !
all buys showing red. False spread showing here. Last years finals were in April...trading update from December very very good. Like this indeed.
Rns out.
Moving up on decent buying now. Plenty of upside given the recent sharp drop. A very good entry opportunity here imo given that the company expects that "full year EBITDA will significantly exceed current market expectations". http://www.investegate.co.uk/cyprotex-plc--crx-/rns/trading-update/201512170909253939J
Continued fall back in sp - anyone know why????
Looks like some profit taking. Not unexpected after recent good performance.
building a solid foundation for 2016.
Cyprotex Earnings To "Significantly" Exceed Market Expectations LONDON (Alliance News) - Cyprotex PLC said Thursday its performance in the last quarter of 2015 has been ahead of expectations, and as a result, its full year earnings before inter [17 Dec '15 09:22]
Still a buy by my standards... should be a fantastic 2016 for this Company.
Excellent Update!
:)
Seek and you will find... Quality...